Reply to IMR: Procedures NOT complied with in GM mosquitoes release!

Contrary to what Dr Lee Han Lim of IMR has written (‘GM mosquitoes: Procedure strictly complied with’ in The Sun, Feb. 6 , http://www.thesundaily.my/news/287130), the GM Aedes mosquitoes release was riddled with non-compliance of international biosafety standards, non-transparency, lack of public accountability and lack of proper due process prior to the GM mosquito release. Moreover, recently revealed data shows that survival rate of the GM mosquitoes can be as high as 15%, not the mere 3% that Dr. Lee claims. 

CAP & SAM Memorandum to the Government on Malaysia’s GM Aedes mosquito planned release

CAP and Sahabat Alam Malaysia (SAM) are deeply concerned of the impending field release of Genetically Modified (GM) mosquitoes after the National Biosafety Board approved an application from the Institute of Medical Research to release GM male Aedes aegypti mosquitoes.

Following this, we are submitting a memorandum to the Malaysian Government raising our concerns on serious ethical, legal, public health and human rights issues which need to be addressed.

An Open Letter to the Government from Malaysian NGOs on genetically engineered Aedes aegypti mosquitoes

This is an open letter from organisations in Malaysia concerned by the recent Government approval to release GM mosquitoes for the purpose of a field experiment.

Kindly support our cause by highlighting the issue for the welfare of the public  and the conservation of our environment by copying and personally sending this letter to its intended recipients.

Sincerely,
S M Mohamed Idris
President
Consumers Association of Penang

Risk Assessment of GM mosquito planned release is incomplete and lacks transparency, says GeneWatch UK

 The Risk Assessment (RA) report of the Malaysian Genetic Modification Advisory Committee (GMAC) on the planned release of GM Aedes mosquitoes in Malaysia is incomplete and the RA process needs to be more transparent. These comments were made in a 13-page report by GeneWatch UK, a scientific organisation involved in genetic engineering and biosafety issues.

GeneWatch UK states that ‘We are concerned that the novelty of this application of GM technology has made regulators in several countries too dependent on advice provided by the company, which has a vested interest in speeding its products into the market place in order to generate financial returns for its investors’.
 

Malaysia’s field release of GM Aedes mosquitoes, purportedly developed by the IMR and the UK based biotech company Oxitec, will be one of the first such experiments in the world.